Interim analysis of a phase II study of the combination of denileukin diftitox (Ontak) and rituximab for relapsed/refractory B-cell non-Hodgkin's lymphoma

• DANG NH

収録刊行物

• Blood

  Blood 106 936a-, 2005

詳細情報

• CRID: 1573105975417297920
• NII論文ID: 10021256886
• データソース種別:
  • CiNii Articles